VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $781,000 | +12.9% | 41,000 | 0.0% | 0.56% | +77.6% |
| Q1 2018 | $692,000 | -38.6% | 41,000 | -44.6% | 0.31% | -36.3% |
| Q4 2017 | $1,127,000 | -14.8% | 74,000 | 0.0% | 0.49% | +2.9% |
| Q3 2017 | $1,323,000 | +9.9% | 74,000 | 0.0% | 0.48% | +3.0% |
| Q2 2017 | $1,204,000 | +16.4% | 74,000 | 0.0% | 0.46% | +18.4% |
| Q1 2017 | $1,034,000 | +24.4% | 74,000 | +42.3% | 0.39% | -16.3% |
| Q4 2016 | $831,000 | -3.9% | 52,000 | 0.0% | 0.47% | -10.2% |
| Q3 2016 | $865,000 | +48.6% | 52,000 | 0.0% | 0.52% | +10.9% |
| Q2 2016 | $582,000 | +34.1% | 52,000 | 0.0% | 0.47% | +225.7% |
| Q1 2016 | $434,000 | +19.6% | 52,000 | +33.3% | 0.14% | -26.5% |
| Q4 2015 | $363,000 | -70.4% | 39,000 | -64.2% | 0.20% | -66.0% |
| Q3 2015 | $1,228,000 | +148.1% | 109,000 | +179.5% | 0.58% | +260.0% |
| Q2 2015 | $495,000 | – | 39,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |